Despite coexisting chronic hepatitis B and thalassemia, the patient’s immune function was not significantly impaired, with inflammatory markers such as PCT, CRP, and IL-6 remaining within normal ranges. This evidence concerns the gene IL6 and chronic hepatitis B virus infection.